社区老年人血清25-羟维生素D水平与肌少症及身体成分的配对病例对照研究
该配对病例对照研究纳入社区新诊断肌少症老年人66例及无肌少症老年人66例,发现肌少症组血清25(OH)D水平显著低于非肌少症组,维生素D缺乏与肌少症风险增加相关,且血清25(OH)D与骨骼肌质量指数呈正相关。
要点
- 肌少症组血清25(OH)D水平显著低于非肌少症组。
- 维生素D缺乏与肌少症风险增加相关(OR 7.75,95%CI 1.96-30.71)。
- 男性血清25(OH)D与SMI正相关、与步速负相关;女性与SMI、骨骼肌质量及去脂体重正相关。
核心结论
- 肌少症老年人血清25(OH)D水平低于无肌少症老年人。
- 维生素D缺乏与肌少症风险增加相关。
- 血清25(OH)D水平与骨骼肌质量指数呈正相关。
研究设计与样本
- 配对病例对照研究,纳入社区新诊断肌少症老年人66例和非肌少症老年人66例。
- 肌少症定义基于亚洲肌少症工作组2019标准。
- 血清25(OH)D采用酶联免疫吸附法测定。
主要发现
- 肌少症组血清25(OH)D为29.08 ± 15.11 ng/mL,非肌少症组为36.28 ± 14.68 ng/mL(P < .05)。
- 维生素D缺乏与肌少症风险增加相关(OR 7.75;95%CI 1.96-30.71)。
- 男性血清25(OH)D与骨骼肌质量指数正相关(r = 0.286;P = .029),与步速负相关(r = -0.282;P = .032)。
- 女性血清25(OH)D与骨骼肌质量指数正相关(r = 0.450;P < .001),与骨骼肌质量正相关(r = 0.395;P < .001),与去脂体重正相关(r = 0.412;P < .001)。
关键数值与推荐
- 肌少症诊断采用亚洲肌少症工作组2019标准。
- 维生素D缺乏与肌少症风险的OR为7.75(95%CI 1.96-30.71)。
临床怎么用
- 社区老年人肌少症评估中可关注血清25(OH)D水平。
- 对维生素D缺乏的老年人,需警惕肌少症风险增加。
- 血清25(OH)D与骨骼肌质量指数相关,可作为肌少症风险辅助参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sarcopenia is a leading health problem among older adults. However, few studies have explored the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels, sarcopenia, and body composition in older Chinese individuals. The aim of this study was to investigate the relationship of serum 25(OH)D levels with sarcopenia, sarcopenia indices, and body composition in community-dwelling older Chinese adults. DESIGN: Paired case-control study. SETTING AND PARTICIPANTS: This case-control study enrolled 66 older adults newly diagnosed with sarcopenia (sarcopenia group) and 66 older adults without sarcopenia (non-sarcopenia group) after screening in the community. METHODS: The definition of sarcopenia was based on the Asian Working Group for Sarcopenia 2019 criteria. Serum levels of 25(OH)D were measured using an enzyme-linked immunosorbent assay. Conditional logistic regression analysis was performed to estimate odds ratios (ORs) and 95% CIs. Spearman's correlation was used to examine the correlations among sarcopenia indices, body composition, and serum 25(OH)D. RESULTS: Serum 25(OH)D levels were significantly lower in the sarcopenia group (29.08 ± 15.11 ng/mL) than in the non-sarcopenia group (36.28 ± 14.68 ng/mL) (P < .05). Vitamin D deficiency was associated with an increased risk of sarcopenia (OR, 7.75; 95% CI, 1.96-30.71). Serum 25(OH)D levels in men were positively correlated with skeletal muscle mass index (SMI) (r = 0.286; P = .029) and negatively correlated with gait speed (r = -0.282; P = .032). Serum 25(OH)D levels in women were positively correlated with SMI (r = 0.450; P < .001), skeletal muscle mass (r = 0.395; P < .001), and fat-free mass (r = 0.412; P < .001). CONCLUSIONS AND IMPLICATIONS: Serum 25(OH)D levels were lower in older adults with sarcopenia than those in adults without sarcopenia. Vitamin D deficiency was associated with increased risk of sarcopenia, and serum 25(OH)D levels were positively correlated with SMI.
引用
- Yang C, Dai Y, Li Z, et al. Relationship of Serum 25-Hydroxyvitamin D Levels with Sarcopenia and Body Composition in Community-Dwelling Older Adults: A Paired Case-Control Study. J Am Med Dir Assoc. 2023. PMID: 37423260. doi:10.1016/j.jamda.2023.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。